(S)-2-((tert-Butoxycarbonyl)amino)-6-guanidinohexanoic acid hydrochloride

Catalog No. :
ACQDUC531
CAS No. :
128719-65-3
Molecular Formula :
C12H25ClN4O4
Molecular Weight :
324.81

IUPAC Name:(S)-2-((tert-Butoxycarbonyl)amino)-6-guanidinohexanoic acid hydrochloride

(S)-2-((tert-Butoxycarbonyl)amino)-6-guanidinohexanoic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$234.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-((tert-Butoxycarbonyl)amino)-6-guanidinohexanoic acid hydrochloride
IUPAC Name(S)-2-((tert-Butoxycarbonyl)amino)-6-guanidinohexanoic acid hydrochloride
MDL No.MFCD00151900
Molecular FormulaC12H25ClN4O4
Molecular Weight324.81
SMILESO=C(O)[C@@H](NC(OC(C)(C)C)=O)CCCCNC(N)=N.[H]Cl
InChI KeyPPMKMWFCZLRHLB-QRPNPIFTSA-N
SynonymBOC-L-HOMOARGININE;BOC-HAR-OH HCL;BOC-HOARG-OH;BOC-HOMOARGININE HCL;BOC-HOMOARG-OH HCL;N-ALPHA-T-BUTOXYCARBONYL-L-HOMOARGININE HYDROCHLORIDE;Boc-L-Homoarginine hydrochloride;(S)-2-(tert-butoxycarbonylamino)-6-guanidinohexanoic acid hydrochloride
CAS No.128719-65-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACQDUC531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIGJL392 route compound structure diagram
    ACIGJL392156-86-5 In Stock
  4. Then
  5. ACQDUC531 route product structure diagram
    ACQDUC531128719-65-3
Inquiry

2. ACQDUC531 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQDUC531 route product structure diagram
    ACQDUC531128719-65-3
Inquiry

Comments (0)